We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+0.34%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$115B
AUM Growth
+$9.78B
Cap. Flow
+$5.11B
Cap. Flow %
4.43%
Top 10 Hldgs %
14.64%
Holding
9,571
New
1,066
Increased
4,008
Reduced
3,386
Closed
872

Sector Composition

Rank Sector Weight
1 Financials 7.82%
2 Industrials 7.49%
3 Consumer Discretionary 7.33%
4 Energy 6.43%
5 Technology 6.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RESI
7076
CALL
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$88K ﹤0.01%
5,200
-10,500
-67% -$198K
AKBA icon
7077
Akebia Therapeutics
AKBA
$248M
$87K ﹤0.01%
+8,462
New +$72.2K
CMPR icon
7078
Cimpress
CMPR
$2.4B
$87K ﹤0.01%
1,030
-20,099
-95% -$1.72M
DLB icon
7079
CALL
Dolby
DLB
$5.84B
$87K ﹤0.01%
2,200
-6,100
-73% -$242K
MDGL icon
7080
Madrigal Pharmaceuticals
MDGL
$12.4B
$87K ﹤0.01%
1,118
-4,938
-82% -$414K
MNRO icon
7081
PUT
Monro
MNRO
$359M
$87K ﹤0.01%
+1,400
New +$87.3K
PIPR icon
7082
PUT
Piper Sandler
PIPR
$5.34B
$87K ﹤0.01%
8,000
-4,000
-33% -$49.9K
RRX icon
7083
PUT
Regal Rexnord
RRX
$11.5B
$87K ﹤0.01%
1,200
-200
-14% -$15.5K
TBPH icon
7084
PUT
Theravance Biopharma
TBPH
$878M
$87K ﹤0.01%
6,700
+5,100
+319% +$79.1K
CPE
7085
DELISTED
Callon Petroleum Company
CPE
$87K ﹤0.01%
1,046
-6,693
-86% -$555K
NXTM
7086
CALL
DELISTED
NxStage Medical Inc.
NXTM
$87K ﹤0.01%
+6,100
New +$103K
ITC
7087
PUT
DELISTED
ITC HOLDINGS CORP
ITC
$87K ﹤0.01%
2,700
-2,600
-49% -$90.6K
BEAT
7088
PUT
DELISTED
BioTelemetry, Inc.
BEAT
$87K ﹤0.01%
9,200
-300
-3% -$2.78K
AMSC icon
7089
American Superconductor
AMSC
$1.56B
$86K ﹤0.01%
+16,442
New +$109K
CNO icon
7090
PUT
CNO Financial Group
CNO
$5.02B
$86K ﹤0.01%
4,700
+2,200
+88% +$39.9K
ENVA icon
7091
CALL
Enova International
ENVA
$6.48B
$86K ﹤0.01%
4,600
+3,900
+557% +$75.8K
EWM icon
7092
iShares MSCI Malaysia ETF
EWM
$332M
$86K ﹤0.01%
1,784
+157
+10% +$8.29K
HOV icon
7093
PUT
Hovnanian Enterprises
HOV
$793M
$86K ﹤0.01%
1,292
-1,692
-57% -$133K
MC icon
7094
CALL
Moelis & Co
MC
$4.91B
$86K ﹤0.01%
3,000
+2,200
+275% +$64.3K
RBA icon
7095
RB Global
RBA
$16B
$86K ﹤0.01%
3,078
-1,788,631
-100% -$49.1M
TVTX icon
7096
PUT
Travere Therapeutics
TVTX
$5.86B
$86K ﹤0.01%
2,600
-7,300
-74% -$200K
UAN icon
7097
CALL
CVR Partners
UAN
$1.26B
$86K ﹤0.01%
680
-580
-46% -$79.3K
NM
7098
PUT
DELISTED
Navios Maritime Holdings Inc.
NM
$86K ﹤0.01%
2,300
+1,180
+105% +$44.6K
PRTK
7099
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$86K ﹤0.01%
+3,319
New +$94.2K
AERI
7100
DELISTED
Aerie Pharmaceuticals
AERI
$86K ﹤0.01%
+4,851
New +$88.9K

Similar funds

Citadel Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, Citadel Advisors held 9,571 positions worth $115B, up 9.3% from $106B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Citadel Advisors deployed $5.11B of net new capital in Q2 2015, opening 1,066 new positions and adding to 4,008 existing holdings. Its largest new stake was Macy's: 3,207,474 shares worth $216M.

By sector, the portfolio is most concentrated in Financials at 7.8% of assets, up from 7.7% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Dollar General, an estimated $323M trimmed.

  • Citadel Advisors's largest Q2 2015 buy was Macy's: 3,207,474 shares worth $216M.
  • Citadel Advisors added most to Chubb in Q2 2015, an estimated $457M increase.
  • Citadel Advisors's biggest Q2 2015 reduction was Dollar General, cutting an estimated $323M.
  • Citadel Advisors fully exited Citizens Financial Group in Q2 2015, selling an estimated $280M.
  • Citadel Advisors's ten largest holdings make up 15% of its $115B portfolio in Q2 2015.
  • Citadel Advisors opened 1,066 new positions and closed 872 in Q2 2015.
  • Citadel Advisors's portfolio value rose 9.3% quarter-over-quarter to $115B.

Based on Citadel Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.